LEADER 5: prevalence and cardiometabolic impact of obesity in cardiovascular high-risk patients with type 2 diabetes mellitus: baseline global data from the LEADER trial

Masmiquel, L.; Leiter, L. A.; Vidal, J.; Bain, S.; Petrie, J.; Franek, E.; Raz, I.; Comlekci, A.; Jacob, S.; Gaal, L. van; M., F. M.; Marso, S. P.; Eriksson, M.; Bain, Steve

doi:10.1186/s12933-016-0341-5

Journal article 1175 views 197 downloads

LEADER 5: prevalence and cardiometabolic impact of obesity in cardiovascular high-risk patients with type 2 diabetes mellitus: baseline global data from the LEADER trial

L. Masmiquel, L. A. Leiter, J. Vidal, S. Bain, J. Petrie, E. Franek, I. Raz, A. Comlekci, S. Jacob, L. van Gaal, F. M. M. Baeres, S. P. Marso, M. Eriksson, Steve Bain

Cardiovascular Diabetology, Volume: 15, Issue: 1

Swansea University Author: Steve Bain

PDF | Version of Record
Download (805.39KB)

Check full text

DOI (Published version): 10.1186/s12933-016-0341-5

Published in:	Cardiovascular Diabetology
ISSN:	1475-2840
Published:	2016
Online Access:	Check full text
URI:	https://cronfa.swan.ac.uk/Record/cronfa25945

Description
Staff View

College:	Faculty of Medicine, Health and Life Sciences
Issue:	1

LEADER 5: prevalence and cardiometabolic impact of obesity in cardiovascular high-risk patients with type 2 diabetes mellitus: baseline global data from the LEADER trial

Similar Items